Sekisui XenoTech LLC is a specialty Contract Research Organisation (CRO) that provides comprehensive drug metabolism and drug-drug interaction studies in preclinical and nonclinical drug development. Renowned for its expertise, Sekisui XenoTech offers a range of in vitro and in vivo contract research studies, particularly in the areas of ADME, DMPK, and Drug-Drug Interactions. The company is dedicated to supporting the pharmaceutical industry through its robust testing and analytical services, helping clients advance their drug development pipelines.

Services include:
– Analytical Services
– ADMET
– Bioanalytical Services
– Consulting
– Contract Research (CRO)
– Drug Development
– Contract Development
– In Vitro Testing
– Testing
– Mass Spectrometry
– Metabolic Analysis
– Nonclinical Research
– Pharmacokinetics
– Preclinical Study Design
– Preclinical Testing

Sekisui XenoTech LLC continues to be a leading provider in the CRO sector, assisting pharmaceutical companies in streamlining their research and development efforts. For more information, please visit xenotech.com.